Volcano Corp (NASDAQ:VOLC)

CAPS Rating: 2 out of 5

The Company is engages in the development, manufacture and commercialization of intravascular ultrasound and functional measurement products that are used for the diagnosis and treatment of vascular and structural heart disease.

Recs

0
Player Avatar APTitus (84.99) Submitted: 10/1/2008 12:48:23 PM : Underperform Start Price: $17.02 VOLC Score: -64.05

covered some shares on 9-20

Featured Broker Partners


Advertisement